SEC Comment Letter 0000000000-24-004531 to Sanofi (SNY, SNYNF) (CIK 0001121404) (SNY)
Sanofi (SNY, SNYNF) (CIK 0001121404)
Date: April 24, 2024 · CIK: 0001121404 · Accession: 0000000000-24-004531
AI Filing Summary & Sentiment
File numbers found in text: 001-31368
Letter
United States securities and exchange commission logo April 24, 2024 Francois Roger Chief Financial Officer Sanofi 46, avenue de la Grande Armée 75017 Paris, France Re:Sanofi Form 20-F for the Fiscal Year Ended December 31, 2023 Filed February 23, 2024 File No. 001-31368 Dear Francois Roger: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
April 24, 2024
Francois Roger
Chief Financial Officer
Sanofi
46, avenue de la Grande Armée
75017 Paris, France
Re:Sanofi
Form 20-F for the Fiscal Year Ended December 31, 2023
Filed February 23, 2024
File No. 001-31368
Dear Francois Roger:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences